Welcome to our dedicated page for Callan JMB news (Ticker: CJMB), a resource for investors and traders seeking the latest updates and insights on Callan JMB stock.
Callan JMB Inc. (NASDAQ: CJMB) is an integrative logistics company focused on highly regulated, temperature‑sensitive supply chains for healthcare, pharmaceuticals, and emergency preparedness. This news page aggregates company‑specific announcements, business updates, and regulatory disclosures so readers can follow how Callan JMB’s logistics, cold chain, and monitoring capabilities evolve over time.
Recent news highlights include strategic agreements and growth initiatives that shape the company’s role in integrated freight and logistics. Callan JMB has reported a strategic teaming agreement with Biostax Corp d/b/a Attune Biotech Inc., under which it will act as an independent third‑party overseer for manufacturing quality assurance, BARDA contract compliance, FDA audit readiness, federal reporting, and Strategic National Stockpile deployment coordination for Attune’s therapeutic pipeline. The company has also announced a strategic realignment toward cold‑chain infrastructure for GLP‑1 medications, including retrofitting its Texas cGMP facility for high‑capacity pharmaceutical‑grade refrigeration and positioning its cold‑chain technology for last‑mile fulfillment.
Other news items cover expansion into the food sampling sector, the launch of a subsidiary in India to establish a temperature‑controlled pharmaceutical warehouse, and upgrades to the proprietary Sentry Monitoring System to version 4.0, enabling web‑based access to temperature data and alarms from any device. Financial results releases provide context on revenue trends, contract extensions such as the long‑term City of Chicago emergency preparedness agreement, and capital markets activities including equity line arrangements.
Investors, analysts, and industry observers can use this page to review Callan JMB’s earnings releases, partnership announcements, technology upgrades, conference participation, and government contract updates, all in one place. Bookmark this feed to quickly access the latest CJMB news as reported in company press releases and SEC‑related communications.
Callan JMB (NASDAQ: CJMB) announced an expansion of its reclamation and logistics operations into the food sampling sector as part of a multi-variant growth strategy on Nov. 10, 2025. The company will apply its regulated-materials expertise—product integrity, recall readiness, and traceability—to sustainable sampling programs.
Callan JMB cited a partnership with AI platform Keychain (supporting $1B in monthly manufacturing projects and connecting 30,000 manufacturers with 20,000 brands) to accelerate market entry. The release references a global food logistics market > $120B growing 6–10% annually as the expansion rationale.
Callan JMB (NASDAQ:CJMB) announced Sentry 4.0, an upgraded version of its Sentry Monitoring System for temperature-sensitive pharmaceutical storage on Oct 13, 2025.
Sentry 4.0 replaces Java with HTML5, enabling access from any web browser on PC, Mac, iPhone, Android, or tablet without downloads. The system retains 24/7/365 active monitoring, alarm notifications, and compliant reporting while improving user accessibility and consistency across devices. The upgrade is available now to new and existing customers.
Callan JMB (NASDAQ: CJMB) announced that its management team will participate in the LD Micro Main Event XIX on October 19-21, 2025. Presentation is scheduled for October 21, 2025 at 12:00 PM PT at Hotel del Coronado, San Diego, CA. A live webcast will be available at https://ldmicrocasts.com/. For access or questions, contact your LD Micro representative or email CallanJMB@kcsa.com.
Callan JMB (NASDAQ: CJMB), a healthcare logistics services provider, has announced its participation in two upcoming investment conferences in September 2025. The company will present at the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10 at the Lotte New York Palace Hotel, with an on-demand presentation available from September 5.
Additionally, management will participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference on September 16-17, presenting at 10:30 a.m. ET. The company will conduct one-on-one investor meetings during both conferences.
[]Callan JMB (NASDAQ: CJMB), a healthcare logistics company, reported Q2 2025 financial results and significant business developments. The company recorded Q2 revenues of $1.7 million and a net loss from operations of $1.4 million.
Key developments include a strategic partnership with Revival Health for integrated supply chain services, launch of an Indian subsidiary with planned temperature-controlled facilities in Pune, and extension of Chicago's emergency preparedness contract through June 2026 with a $1.5 million funding increase to $9.1 million total. The company also appointed Christopher Shields as SVP of Emergency Preparedness & Response and successfully managed a measles outbreak response.
Post-quarter, Callan JMB secured a $25 million equity line of credit to support growth initiatives in GLP-1 pharmaceutical distribution, specialty compounding pharmacy logistics, and premium food packaging solutions.
Callan JMB (NASDAQ: CJMB) has secured a contract extension with the City of Chicago through June 2026, marking a significant development in their seven-year partnership. The contract, focused on Health Preparedness Supplies and Related Services, includes a $1.5 million funding increase, bringing the total contract value to $9.1 million.
Through its subsidiary Coldchain Technology Services, Callan JMB will continue providing pallet storage and emergency supplies management services for Chicago residents. The extension ensures uninterrupted service delivery in emergency preparedness and response capabilities.
Callan JMB (NASDAQ: CJMB) has established a new subsidiary, Callan JMB Services (India) Private Limited, to expand its logistics services in India. The company plans to open a temperature-controlled warehouse in Pune, Maharashtra capable of storing pharmaceuticals at various temperatures, including -80°C for tissue samples.
The subsidiary, incorporated on June 20, 2025, will facilitate pharmaceutical distribution within India and help Indian companies establish manufacturing operations in the U.S. The company has already secured an agreement with Walker's Pharmaceuticals and is collaborating with Brihans Natural Products for U.S. manufacturing setup and distribution services.
Callan JMB (NASDAQ: CJMB), a healthcare and emergency management logistics company, has announced its participation in Maxim Group's 2025 Virtual Tech Conference. The company will engage in a fireside chat on June 3, 2025, at 10:30 a.m. ET. The conference, themed "Discover the Innovations Reshaping Tomorrow," will run from June 3-5, 2025.
Callan JMB specializes in fulfillment, storage, monitoring, and cold chain logistics services for the healthcare industry and emergency management agencies. Interested parties can register through the provided link or contact KCSA Strategic Communications for meetings.